Please assess the completion status of the following clinical trial:

Trial Title: Assessment of VZV-specific ELISPOT Assay for Predicting VZV Infection in Kidney Transplant Recipients (AVE-KT)

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* age 16 years or more~* agree with written informed consent~* WBC count 2000/uL or more~Exclusion Criteria:~* no exclusion criteria

- Gender: ALL
- Minimum Age: 16 Years
- Maximum Age: 99 Years
- Healthy Volunteers: f

Study Arms:
- high VZV ELISPOT results (Type: None): high spot counts in ELISPOT
- low VZV ELISPOT results (Type: None): low spot counts in ELISPOT

Based on this trial design, predict the completion outcome and termination type (if applicable).